GO
Loading...

Markets

Markets Overview

  Price   Change %Change
S&P 500
---
DJIA
---
VIX
---

  Price   Change %Change
FTSE
---
NIKKEI
---
HSI
---

  Price   Change %Change
OIL
---
GOLD
---
CORN
---

  Price   Change %Change
US 10-YR
---
EUR/USD
---
USD/JPY
---

US Markets

  Price   Change %Change
DJIA
---
S&P 500
---
NASDAQ
---
RUSS 2K
---
VIX
---

Europe Markets

  Price   Change %Change
DAX
---
FTSE
---
CAC 40
---
AEX
---
BEL 20
---

Asia-Pacific Markets

  Price   Change %Change
NIKKEI
---
SHANGHAI
---
HSI
---
ASX 200
---
KOSPI
---
STI
---

Commodities

  Price   Change %Change
OIL
---
NAT GAS
---
GOLD
---
SILVER
---
WHEAT
---

Bonds

  Price   Change %Change
US 10-YR
---
GER 10-YR
---
JPN 10-YR
---
US 3-MO
---
US 2-YR
---
US 5-YR
---
US 30-YR
---

Contact Markets

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Most Popular Video

Wednesday, 23 Apr 2014 | 7:33 AM ET

J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.

Wednesday, 23 Apr 2014 | 6:13 AM ET

Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.

Wednesday, 23 Apr 2014 | 4:10 AM ET

Fraser Howie, director at Newedge Singapore, says the PMI data reveals China is "in a bit of a rut" and that the government has a "horrible problem" as it can't bring out too much stimulus.